Clinical Trial Update: Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia [Phase 2]

View source ↗

Summary

Investigator-initiated Phase 2 clinical trial evaluating safety and efficacy in frontotemporal dementia; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Snippet

Sponsor: Hee-Jin Kim | Conditions: Dementia Frontotemporal | Phase 2 | Status: NOT_YET_RECRUITING